AVI BioPharma Feasibility Study

Customer: AVI BioPharma Inc.
Project Location:Corvallis, Oregon

AVI BioPharma is focused on the discovery and development of RNA-based drugs utilizing proprietary derivatives of its antisense chemistry (morpholino-modified osphorodiamidate oligomers or PMOs) that can be applied to a wide range of diseases and genetic disorders through several district mechanisms of action.

The Challenge

AVI BioPharma required the development of P&IDs for the Medium Scale Production Facility, an address of the drying of specific critical process streams to isolate intermediates and/or products, and process design assistance to determine how best to scale-up and optimize the AVI processes.

The Solution

Harris Group provided a conceptual study that provided the approach to meet the goals of the project.

The Benefits

The conceptual study allowed AVI BioPharma the opportunity to review overall plans and approach to expanding their operations, improving their compliance, and optimizing their process.